Obesity and the Risk and Detection of Fetal Malformations

Seminars in Perinatology

Volumn 36, Issue 3, 2012, Pages 213-221

  Racusin, Diana ^a   Stevens, Blair ^a   Campbell, Genevieve ^a   Aagaard, Kjersti M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Fetal cardiac malformations; Fetal malformations; Genetic sonogram; Maternal obesity; Open neural tube defects; Pregnancy; Prenatal diagnosis

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

BODY MASS; CLEFT FACE; CONGENITAL HEART MALFORMATION; DIABETIC OBESITY; DIABETOGENESIS; DISEASE ASSOCIATION; FEEDING BEHAVIOR; FETUS ECHOGRAPHY; FETUS MALFORMATION; FETUS RISK; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; HYPERGLYCEMIA; INCIDENCE; INSULIN RESISTANCE; LIPID DIET; MATERNAL AGE; MATERNAL ATTITUDE; MATERNAL DIABETES MELLITUS; MATERNAL NUTRITION; MATERNAL OBESITY; MATERNAL SERUM; MORBID OBESITY; NEURAL TUBE DEFECT; NUCLEAR MAGNETIC RESONANCE IMAGING; OROFACIAL CLEFT; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY;

BODY MASS INDEX; CLEFT PALATE; CONGENITAL ABNORMALITIES; DIABETES, GESTATIONAL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; NEURAL TUBE DEFECTS; OBESITY; OVERWEIGHT; PREGNANCY; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 84862581483     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2012.05.001     Document Type: Review

References (67)

1. Dennedy M.C., Dunne F. The maternal and fetal impacts of obesity and gestational diabetes on pregnancy outcome. Best Pract Res Clin Endocrinol Metab 2010, 24:573-589.
2. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
3. Field A.E., Coakley E.H., Must A., et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001, 161:1581-1586.
4. Weiss J.L., Malone F.D., Emig D., et al. Obesity, obstetric complications and cesarean delivery rate-A population-based screening study. Am J Obstet Gynecol 2004, 190:1091-1097.
5. Cnattingius S., Bergström R., Lipworth L., et al. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998, 338:147-152.
6. Robinson H.E., O'Connell C.M., Joseph K.S., et al. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol 2005, 106:1357-1364.
7. UshaKiran T.S., Hemmadi S., Bethel J., et al. Outcome of pregnancy in a woman with increased body mass index. Br J Obstet Gynaecol 2005, 112:768-772.
8. Hendler I., Blackwell S.C., Bujold E., et al. The impact of maternal obesity on midtrimester sonographic visualization of fetal cardiac and craniospinal structures. Int J Obes Relat Metab Disord 2004, 28:1607-1611.
9. Watkins M.L., Botto L.D. Maternal prepregnancy weight and congenital heart defects in the offspring. Epidemiology 2001, 11:439-446.
10. Shaw G.M., Velie E.M., Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA 1996, 275:1093-1096.
11. Wong S.F., Chan F.Y., Cincotta R.B., et al. Routine ultrasound screening in diabetic pregnancies. Ultrasound Obstet Gynecol 2002, 19:171-176.
12. Watkins M.L., Rasmussen S.A., Honein M.A., et al. Maternal obesity and risk for birth defects. Pediatrics 2003, 111:1152-1158.
13. Cedergren M.I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004, 103:219-224.
14. Stothard K.J., Tennant P.W., Bell R., et al. Maternal overweight and obesity and the risk of congenital anomalies: A systematic review and meta-analysis. JAMA 2009, 301:636-650.
15. Wereler M.M., Louik C., Shapiro S., et al. Prepregnant weight in relation to risk of neural tube defect. JAMA 1996, 275:1089-1092.
16. Anderson J.L., Waller D.K., Canfield M.A., et al. Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology 2005, 16:87-92.
17. Waller D.K., Shaw G.M., Rasmussen S.A., et al. National Birth Defects Prevention Study: Prepregnancy obesity as a risk factor for structural defects. Arch Pediatr Adolesc Med 2007, 161:745-750.
18. Aagaard-Tillery K.M., Porter T.F., Malone F.D., et al. Influence of maternal BMI on genetic sonography in the FaSTER trial. Prenat Diagn 2010, 30:14-22.
19. Wolfe H.M., Sokol R.J., Martier S.M., et al. Maternal obesity: A potential source of error in sonographic prenatal diagnosis. Obstet Gynecol 1990, 76:339-342.
20. DeVore G.R., Medearis A.L., Bear M.B., et al. Fetal echocardiography: Factors that influence imaging of the fetal heart during the second trimester of pregnancy. J Ultrasound Med 1993, 12:659-663.
21. Schwärzler P., Senat M.V., Holden D., et al. Feasibility of the second-trimester fetal ultrasound examination in an unselected population at 18, 20, or 22 weeks of pregnancy: A randomized trial. Ultrasound Obstet Gynecol 1999, 14:92-97.
22. Rosenberg J.C., Guzman E.R., Vintzileos A.M., et al. Transumbilical placement of the vaginal probe in obese pregnant women. Obstet Gynecol 1995, 85:132-134.
23. ACOG Committee Opinion number 315, September 2005. Obesity in pregnancy. Obstet Gynecol 2005, 106:671-675. American College of Obstetricians and Gynecologists.
24. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004, 291:2847-2850.
25. Aagaard-Tillery K.M., Suter M.A., Harris R.A., et al. Epigenetics and reproduction and the developmental origins of health and disease. Anim Reprod 2010, 7:103-116.
26. Suter M.A., Bocock P.N., Showalter L., et al. Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates. FASEB J 2010, 25:714-726.
27. Aagaard-Tillery K.M., Grove K., Bishop J., et al. Developmental origins of disease and determinants of chromatin structure: Maternal diet modifies the primate fetal epigenome. J Mol Endocrinol 2008, 41:91-102.
28. Cox J., Williams S., Grove K., et al. A maternal high fat diet is accompanied by alterations in the fetal primate metabolome. Am J Obstet Gynecol 2009, 201:e1-e9.
29. McCurdy C.E., Bishop J.M., Williams S.M., et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009, 119:323-335.
30. Simmons D. Diabetes and obesity in pregnancy. Best Pract Res Clin Obstet Gynaecol 2011, 25:25-36.
31. Catalano P.M. Obesity, insulin resistance, and pregnancy outcome. Reproduction 2010, 140:365-371.
32. Metzger B.E., Lowe L.P., et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008, 358:1991-2002. HAPO Study Cooperative Research Group.
33. Waller D.K., Mills J.L., Simpson J.L., et al. Are obese women at higher risk for producing malformed offspring?. Am J Obstet Gynecol 1994, 170:541-548.
34. Rasmussen S.A., Chu S.Y., Kim S.Y., et al. Maternal obesity and risk of neural tube defects: A metaanalysis. Am J Obstet Gynecol 2008, 198:611-619.
35. Cedergren M., Källén B. Maternal obesity and the risk for orofacial clefts in the offspring. Cleft Palate Craniofac J 2005, 42:367-371.
36. Torloni M.R., Betrán A.P., Horta B.L., et al. Prepregnancy BMI and the risk of gestational diabetes: A systematic review of the literature with meta-analysis. Obes Rev 2009, 10:194-203.
37. Reece E.A. Perspectives on obesity, pregnancy and birth outcomes in the United States: The scope of the problem. Am J Obstet Gynecol 2008, 198:23-27.
38. Sheffield J.S., Butler-Koster E.L., Casey B.M., et al. Maternal diabetes mellitus and infant malformations. Obstet Gynecol 2002, 100:925-930.
39. Chu S.Y., Callaghan W.M., Kim S.Y., et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007, 30:2070-2076.
40. Cedergren M.I., Källén B.A. Maternal obesity and infant heart defects. Obes Res 2003, 11:1065-1071.
41. Blomberg M.I., Källén B. Maternal obesity and morbid obesity: The risk for birth defects in the offspring. Birth Defects Res A Clin Mol Teratol 2010, 88:35-40.
42. Martínez-Frías M.L., Frías J.P., Bermejo E., et al. Pre-gestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes. Diabet Med 2005, 22:775-781.
43. Blencowe H., Cousens S., Modell B., et al. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 2010, 39:10-20.
44. Ray J.G., Wyatt P.R., Vermeulen M.J., et al. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol 2005, 105:261-265.
45. Wilson R.D., Johnson J.A., Wyatt P., et al. Preconceptional vitamin/folic acid supplementation 2007: The use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2007, 12:1003-1026.
46. Mahabir S., Ettinger S., Johnson L., et al. Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study. Eur J Clin Nutr 2008, 62:644-650.
47. Toh S.Y., Zarshenas N., Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition 2009, 25:1150-1156.
48. Wax J.R. Risks and management of obesity in pregnancy: Current controversies. Curr Opin Obstet Gynecol 2009, 21:117-123.
49. Culver J.C., Dickinson M.E. The effects of hemodynamic force on embryonic development. Microcirculation 2010, 17:164-178.
50. Poché R.A., Larina I.V., Scott M.L., et al. The Flk1-myr::mCherry mouse as a useful reporter to characterize multiple aspects of ocular blood vessel development and disease. Dev Dyn 2009, 238:2318-2326.
51. Lucitti J.L., Jones E.A., Huang C., et al. Vascular remodeling of the mouse yolk sac requires hemodynamic force. Development 2007, 52:752-760.
52. ACOG Practice Bulletin No. 77: Screening for fetal chromosomal abnormalities. Obstet Gynecol 2007, 109:217-227. ACOG Committee on Practice Bulletins.
53. Palomaki G.E., Panizza D.S., Canick J.A. Screening for Down syndrome using AFP, uE3, and hCG: Effect of maternal weight. Am J Hum Genet 1990, 7:a282.
54. Neveux L.M., Palomaki G.E., Larrivee D.A., et al. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn 1996, 16:1115-1119.
55. Wald N.J., Cuckle H.S., Densem J.W., et al. Maternal serum screening for Down syndrome: The effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol 1992, 99:144-149.
56. Gandhi M., Fox N.S., Russo-Stieglitz K., et al. Effect of increased body mass index on first-trimester ultrasound examination for aneuploidy risk assessment. Obstet Gynecol 2009, 114:856-859.
57. Wax J.R., Pinette M.G., Cartin A., et al. The value of repeated evaluation after initial failed nuchal translucency measurement. J Ultrasound Med 2007, 26:825-828.
58. Johnson A.M., Palomaki G.E., Haddow J.E. The effect of adjusting maternal serum alpha-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida. A United States collaborative study. Am J Obstet Gynecol 1990, 163:9-11.
59. Thornburgh L.L., Mulconry M., Post A., et al. Fetal nuchal translucency thickness evaluation in the overweight and obese gravid. Ultrasound Obstet Gynecol 2009, 33:665-669.
60. Wald N.J., Kennard A., Hackshaw A., et al. Prenatal screening for Down syndrome. Prenat Diagn 1997, 4:181-246.
61. Sancken U., Bartels I. Biochemical screening for chromosomal disorders and neural tube defects (NTDs): Is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?. Prenat Diagn 2001, 21:383-386.
62. Dashe J.S., McIntire D.D., Twickler D.M. Maternal obesity limits the ultrasound evaluation of fetal anatomy. J Ultrasound Med 2009, 28:1025-1030.
63. Aagaard-Tillery K.M., Malone F.D., Nyberg D.A., et al. Role of second-trimester genetic sonography following Down syndrome screening. Obstet Gynecol 2009, 114:1189-1196.
64. Maxwell C., Glanc P. Imaging and obesity: A perspective during pregnancy. AJR Am J Roentgenol 2011, 196:311-319.
65. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005, 353:2001-2011.
66. Bromley B., Lieberman E., Shipp T.D., et al. The genetic sonogram: A method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med 2002, 21:1087-1096.
67. Hobbins J.C., Lezotte D.C., Persutte W.H., et al. An 8-center study to evaluate the utility of mid-term genetic sonograms among high-risk pregnancies. J Ultrasound Med 2003, 22:33-38.